|
Volumn 46, Issue 2, 2007, Pages 608-
|
Reply [8]
a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIVIRUS AGENT;
BILIRUBIN;
HEPATITIS B SURFACE ANTIGEN;
HEPATITIS B(E) ANTIGEN;
LAMIVUDINE;
PLACEBO;
VIRUS ANTIGEN;
VIRUS DNA;
ACUTE HEPATITIS;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
DISEASE SEVERITY;
HEPATIC ENCEPHALOPATHY;
HEPATITIS B;
HEPATITIS B VIRUS;
HUMAN;
IMMUNE RESPONSE;
INTERNATIONAL NORMALIZED RATIO;
LETTER;
LIVER TRANSPLANTATION;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
REAL TIME POLYMERASE CHAIN REACTION;
RISK ASSESSMENT;
|
EID: 34548321203
PISSN: 02709139
EISSN: None
Source Type: Journal
DOI: 10.1002/hep.21882 Document Type: Letter |
Times cited : (1)
|
References (6)
|